Cholesterol and the development of clear-cell renal carcinoma

Current Opinion in Pharmacology

Volumn 12, Issue 6, 2012, Pages 742-750

  Drabkin, Harry A ^a   Gemmill, Robert M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AXITINIB; BEVACIZUMAB; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; EVEROLIMUS; GLYCOGEN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR; INTERLEUKIN 2; LIPID; MEVALONIC ACID; PAZOPANIB; PROTEIN TRC8; SORAFENIB; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SUNITINIB; TEMSIROLIMUS; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BYSTANDER EFFECT; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL TRANSFORMATION; CHOLESTEROL SYNTHESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRYOABLATION; DRUG MEGADOSE; FAMILIAL CANCER; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; KIDNEY CARCINOMA; LIPID STORAGE; LIPOGENESIS; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NEPHRECTOMY; NEPHRON SPARING SURGERY; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; TUMOR GENE;

EID: 84870500730     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.08.002     Document Type: Review

References (65)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. B. Ljungberg, S.C. Campbell, H.Y. Choi, D. Jacqmin, J.E. Lee, S. Weikert, and L.A. Kiemeney The epidemiology of renal cell carcinoma Eur Urol 60 2011 615 621
3. H.A. Drabkin, and R.M. Gemmill Obesity, cholesterol, and clear-cell renal cell carcinoma (rcc) Adv Cancer Res 107 2010 39 56
4. M. Sun, R. Thuret, F. Abdollah, G. Lughezzani, J. Schmitges, Z. Tian, S.F. Shariat, F. Montorsi, J.J. Patard, P. Perrotte, and P.I. Karakiewicz Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in north america: a trend analysis Eur Urol 59 2011 135 141
5. H. Yang, Y.A. Minamishima, Q. Yan, S. Schlisio, B.L. Ebert, X. Zhang, L. Zhang, W.Y. Kim, A.F. Olumi, and W.G. Kaelin Jr. Pvhl acts as an adaptor to promote the inhibitory phosphorylation of the nf-kappab agonist card9 by ck2 Mol Cell 28 2007 15 27
6. T. Kobayashi, Y. Hirayama, E. Kobayashi, Y. Kubo, and O. Hino A germline insertion in the tuberous sclerosis (tsc2) gene gives rise to the eker rat model of dominantly inherited cancer Nat Genet 9 1995 70 74
7. S. Vanharanta, M. Buchta, S.R. McWhinney, S.K. Virta, M. Peczkowska, C.D. Morrison, R. Lehtonen, A. Januszewicz, H. Jarvinen, and M. Juhola Early-onset renal cell carcinoma as a novel extraparaganglial component of sdhb-associated heritable paraganglioma Am J Hum Genet 74 2004 153 159
8. J. Adam, E. Hatipoglu, L. O'Flaherty, N. Ternette, N. Sahgal, H. Lockstone, D. Baban, E. Nye, G.W. Stamp, and K. Wolhuter Renal cyst formation in fh1-deficient mice is independent of the hif/phd pathway: roles for fumarate in keap1 succination and nrf2 signaling Cancer Cell 20 2011 524 537
9. S.J. Mandriota, K.J. Turner, D.R. Davies, P.G. Murray, N.V. Morgan, H.M. Sowter, C.C. Wykoff, E.R. Maher, A.L. Harris, P.J. Ratcliffe, and P.H. Maxwell Hif activation identifies early lesions in vhl kidneys: evidence for site-specific tumor suppressor function in the nephron Cancer Cell 1 2002 459 468
10. K. Kondo, W.Y. Kim, M. Lechpammer, and W.G. Kaelin Jr. Inhibition of hif2alpha is sufficient to suppress pvhl-defective tumor growth PLoS Biol 1 2003 E83
11. I. Varela, P. Tarpey, K. Raine, D. Huang, C.K. Ong, P. Stephens, H. Davies, D. Jones, M.L. Lin, and J. Teague Exome sequencing identifies frequent mutation of the swi/snf complex gene pbrm1 in renal carcinoma Nature 469 2011 539 542
12. G.L. Dalgliesh, K. Furge, C. Greenman, L. Chen, G. Bignell, A. Butler, H. Davies, S. Edkins, C. Hardy, and C. Latimer Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
13. C. Shen, R. Beroukhim, S.E. Schumacher, J. Zhou, M. Chang, S. Signoretti, and W.G. Kaelin Jr. Genetic and functional studies implicate hif1alpha as a 14q kidney cancer suppressor gene Cancer Discov 1 2011 222 235
14. N.S. Kenneth, S. Mudie, P. van Uden, and S. Rocha Swi/snf regulates the cellular response to hypoxia J Biol Chem 284 2009 4123 4131
15. S. Pena-Llopis, S. Vega-Rubin-de-Celis, A. Liao, N. Leng, A. Pavia-Jimenez, S. Wang, T. Yamasaki, L. Zhrebker, S. Sivanand, and P. Spence Bap1 loss defines a new class of renal cell carcinoma Nat Genet 44 2012 751 759
16. S.L. Topalian, F.S. Hodi, J.R. Brahmer, S.N. Gettinger, D.C. Smith, D.F. McDermott, J.D. Powderly, R.D. Carvajal, J.A. Sosman, and M.B. Atkins Safety, activity, and immune correlates of anti-pd-1 antibody in cancer N Engl J Med 366 2012 2443 2454
17. Y. Jo, P.C. Lee, P.V. Sguigna, and R.A. DeBose-Boyd Sterol-induced degradation of hmg coa reductase depends on interplay of two insigs and two ubiquitin ligases, gp78 and trc8 Proc Natl Acad Sci USA 108 2011 20503 20508
18. J.P. Lee, A. Brauweiler, M. Rudolph, J.E. Hooper, H.A. Drabkin, and R.M. Gemmill The trc8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways Mol Cancer Res 8 2010 93 106
19. J.N. Lee, B. Song, R.A. DeBose-Boyd, and J. Ye Sterol-regulated degradation of insig-1 mediated by the membrane-bound ubiquitin ligase gp78 J Biol Chem 281 2006 39308 39315
20. T. Porstmann, C.R. Santos, B. Griffiths, M. Cully, M. Wu, S. Leevers, J.R. Griffiths, Y.L. Chung, and A. Schulze Srebp activity is regulated by mtorc1 and contributes to akt-dependent cell growth Cell Metab 8 2008 224 236
21. A. Sundqvist, M.T. Bengoechea-Alonso, X. Ye, V. Lukiyanchuk, J. Jin, J.W. Harper, and J. Ericsson Control of lipid metabolism by phosphorylation- dependent degradation of the srebp family of transcription factors by scf(fbw7) Cell Metab 1 2005 379 391
22. T.R. Peterson, S.S. Sengupta, T.E. Harris, A.E. Carmack, S.A. Kang, E. Balderas, D.A. Guertin, K.L. Madden, A.E. Carpenter, B.N. Finck, and D.M. Sabatini Mtor complex 1 regulates lipin 1 localization to control the srebp pathway Cell 146 2011 408 420
23. M.D. Siperstein Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth J Lipid Res 25 1984 1462 1468
24. N.I. Azrolan, and P.S. Coleman A discoordinate increase in the cellular amount of 3-hydroxy-3-methylglutaryl-coa reductase results in the loss of rate-limiting control over cholesterogenesis in a tumour cell-free system Biochem J 258 1989 421 425
25. J.W. Clendening, A. Pandyra, P.C. Boutros, S. El Ghamrasni, F. Khosravi, G.A. Trentin, A. Martirosyan, A. Hakem, R. Hakem, I. Jurisica, and L.Z. Penn Dysregulation of the mevalonate pathway promotes transformation Proc Natl Acad Sci USA 107 2010 15051 15056
26. W.A. Freed-Pastor, H. Mizuno, X. Zhao, A. Langerod, S.H. Moon, R. Rodriguez-Barrueco, A. Barsotti, A. Chicas, W. Li, and A. Polotskaia Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway Cell 148 2012 244 258
27. M. Osmak Statins and cancer: current and future prospects Cancer Lett 324 2012 1 12
28. R.L. Gebhard, R.V. Clayman, W.F. Prigge, R. Figenshau, N.A. Staley, C. Reesey, and A. Bear Abnormal cholesterol metabolism in renal clear cell carcinoma J Lipid Res 28 1987 1177 1184
29. V. Tugnoli, A. Trinchero, and M.R. Tosi Evaluation of the lipid composition of human healthy and neoplastic renal tissues Ital J Biochem 53 2004 169 182
30. K. Matsumoto, Y. Fujiwara, R. Nagai, M. Yoshida, and S. Ueda Expression of two isozymes of acyl-coenzyme A:cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma Int J Urol 15 2008 166 170
31. M.R. Paillasse, P. de Medina, G. Amouroux, L. Mhamdi, M. Poirot, and S. Silvente-Poirot Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion J Lipid Res 50 2009 2203 2211
32. S. Pal, K.P. Claffey, H.T. Cohen, and D. Mukhopadhyay Activation of sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase c zeta J Biol Chem 273 1998 26277 26280
33. S.M. Post, J.P. Zoeteweij, M.H. Bos, E.C. de Wit, R. Havinga, F. Kuipers, and H.M. Princen Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat Hepatology 30 1999 491 500
34. P. de Medina, B.L. Payre, J. Bernad, I. Bosser, B. Pipy, S. Silvente-Poirot, G. Favre, J.C. Faye, and M. Poirot Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells J Pharmacol Exp Ther 3 2004 1165 1173
35. P. de Medina, M.R. Paillasse, G. Segala, M. Poirot, and S. Silvente-Poirot Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and aebs ligands Proc Natl Acad Sci USA 107 2010 13520 13525
36. A. de Weerth, L. Jonas, R. Schade, T. Schoneberg, G. Wolf, A. Pace, F. Kirchhoff, M. Schulz, T. Heinig, H. Greten, and T. von Schrenck Gastrin/cholecystokinin type b receptors in the kidney: molecular, pharmacological, functional characterization, and localization Eur J Clin Invest 28 1998 592 601
37. C. Chao, E. Goluszko, Y.T. Lee, A.A. Kolokoltsov, R.A. Davey, T. Uchida, C.M. Townsend Jr., and M.R. Hellmich Constitutively active cck2 receptor splice variant increases src-dependent hif-1 alpha expression and tumor growth Oncogene 26 2007 1013 1019
38. M. Wang, R. Xie, R. Liu, X. Jia, Y. Bao, and X. Liu Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy Endocrine 2012 10.1007/s12020-012-9630-2
39. L. Sun, N. Halaihel, W. Zhang, T. Rogers, and M. Levi Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus J Biol Chem 277 2002 18919 18927
40. S. Jones, T.L. Wang, M. Shih Ie, T.L. Mao, K. Nakayama, R. Roden, R. Glas, D. Slamon, L.A. Diaz Jr., and B. Vogelstein Frequent mutations of chromatin remodeling gene arid1a in ovarian clear cell carcinoma Science 330 2010 228 231
41. S. Jones, M. Li, D.W. Parsons, X. Zhang, J. Wesseling, P. Kristel, M.K. Schmidt, S. Markowitz, H. Yan, and D. Bigner Somatic mutations in the chromatin remodeling gene arid1a occur in several tumor types Hum Mutat 33 2012 100 103
42. M.S. Anglesio, J. George, H. Kulbe, M. Friedlander, D. Rischin, C. Lemech, J. Power, J. Coward, P.A. Cowin, and C.M. House Il6-stat3-hif signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer Clin Cancer Res 17 2011 2538 2548
43. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, R.G. Holzer, C.H. Osterreicher, H. Takahashi, and M. Karin Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing il-6 and tnf expression Cell 140 2010 197 208
44. N. Yahagi, H. Shimano, A.H. Hasty, T. Matsuzaka, T. Ide, T. Yoshikawa, M. Amemiya-Kudo, S. Tomita, H. Okazaki, and Y. Tamura Absence of sterol regulatory element-binding protein-1 (srebp-1) ameliorates fatty livers but not obesity or insulin resistance in lep(ob)/lep(ob) mice J Biol Chem 277 2002 19353 19357
45. Y. Li, S. Xu, M.M. Mihaylova, B. Zheng, X. Hou, B. Jiang, O. Park, Z. Luo, E. Lefai, and J.Y. Shyy Ampk phosphorylates and inhibits srebp activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Cell Metab 13 2011 376 388
46. N. Kambham, G.S. Markowitz, A.M. Valeri, J. Lin, and V.D. D'Agati Obesity-related glomerulopathy: an emerging epidemic Kidney Int 59 2001 1498 1509
47. T. Jiang, Z. Wang, G. Proctor, S. Moskowitz, S.E. Liebman, T. Rogers, M.S. Lucia, J. Li, and M. Levi Diet-induced obesity in c57bl/6j mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway J Biol Chem 280 2005 32317 32325
48. C. Ruggiero, M. Ehrenshaft, E. Cleland, and K. Stadler High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ros production Am J Physiol Endocrinol Metab 300 2011 E1047 E1058
49. H. Jun, Z. Song, W. Chen, R. Zanhua, S. Yonghong, L. Shuxia, and D. Huijun In vivo and in vitro effects of srebp-1 on diabetic renal tubular lipid accumulation and rnai-mediated gene silencing study Histochem Cell Biol 131 2009 327 345
50. A.J. Cohen, F.P. Li, S. Berg, D.J. Marchetto, S. Tsai, S.C. Jacobs, and R.S. Brown Hereditary renal-cell carcinoma associated with a chromosomal translocation N Engl J Med 301 1979 592 595
51. R.M. Gemmill, J.D. West, F. Boldog, N. Tanaka, L.J. Robinson, D.I. Smith, F. Li, and H.A. Drabkin The hereditary renal cell carcinoma 3;8 translocation fuses fhit to a patched-related gene, trc8 Proc Natl Acad Sci USA 95 1998 9572 9577
52. K.S. Poland, M. Azim, M. Folsom, R. Goldfarb, R. Naeem, C. Korch, H.A. Drabkin, R.M. Gemmill, and S.E. Plon A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the trc8 gene and predisposition to clear cell renal cell carcinoma Genes Chromosomes Cancer 46 2007 805 812
53. S. Gimelli, S. Beri, H.A. Drabkin, C. Gambini, A. Gregorio, P. Fiorio, O. Zuffardi, R.M. Gemmill, R. Giorda, and G. Gimelli The tumor suppressor gene trc8/rnf139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma Mol Cancer 8 2009 52
54. F.P. Li, H.J. Decker, B. Zbar, V.P. Stanton Jr., G. Kovacs, B.R. Seizinger, H. Aburatani, A.A. Sandberg, S. Berg, S. Hosoe, and R.S. Brown Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation, Genetics of familial renal carcinoma Ann Intern Med 118 1993 106 111
55. K.L. Lorick, J.P. Jensen, S. Fang, A.M. Ong, S. Hatakeyama, and A.M. Weissman Ring fingers mediate ubiquitin-conjugating enzyme (e2)-dependent ubiquitination Proc Natl Acad Sci USA 96 1999 11364 11369
56. R.M. Gemmill, L.T. Bemis, J.P. Lee, M.A. Sozen, A. Baron, C. Zeng, P.F. Erickson, J.E. Hooper, and H.A. Drabkin The trc8 hereditary kidney cancer gene suppresses growth and functions with vhl in a common pathway Oncogene 21 2002 3507 3516
57. A. Brauweiler, K.L. Lorick, J.P. Lee, Y.C. Tsai, D. Chan, A.M. Weissman, H.A. Drabkin, and R.M. Gemmill Ring-dependent tumor suppression and g2/m arrest induced by the trc8 hereditary kidney cancer gene Oncogene 26 2007 2263 2271
58. P.H. Lin, W.M. Lan, and L.Y. Chau Trc8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation Oncogene 2012 10.1038/onc.2012.244
59. G.M. DeNicola, F.A. Karreth, T.J. Humpton, A. Gopinathan, C. Wei, K. Frese, D. Mangal, K.H. Yu, C.J. Yeo, and E.S. Calhoun Oncogene-induced nrf2 transcription promotes ros detoxification and tumorigenesis Nature 475 2011 106 109
60. A. Ooi, J.C. Wong, D. Petillo, D. Roossien, V. Perrier-Trudova, D. Whitten, B.W. Min, M.H. Tan, Z. Zhang, and X.J. Yang An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma Cancer Cell 20 2011 511 523
61. A. Kallin, L.E. Johannessen, P.D. Cani, C.Y. Marbehant, A. Essaghir, F. Foufelle, P. Ferre, C.H. Heldin, N.M. Delzenne, and J.B. Demoulin Srebp-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma J Lipid Res 48 2007 1628 1636
62. M.L. Nickerson, M.B. Warren, J.R. Toro, V. Matrosova, G. Glenn, M.L. Turner, P. Duray, M. Merino, P. Choyke, and C.P. Pavlovich Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome Cancer Cell 2 2002 157 164
63. M. Baba, S.B. Hong, N. Sharma, M.B. Warren, M.L. Nickerson, A. Iwamatsu, D. Esposito, W.K. Gillette, R.F. Hopkins 3rd, and J.L. Hartley Folliculin encoded by the bhd gene interacts with a binding protein, fnip1, and ampk, and is involved in ampk and mtor signaling Proc Natl Acad Sci USA 103 2006 15552 15557
64. Z.H. Beg, J.A. Stonik, and H.B. Brewer Jr. Characterization and regulation of reductase kinase, a protein kinase that modulates the enzymic activity of 3-hydroxy-3-methylglutaryl-coenzyme a reductase Proc Natl Acad Sci USA 76 1979 4375 4379
65. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, and N. Fujii Role of amp-activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174